Docoh
Loading...

Filter options loading...
Top filers
Top filing types
Recent filing years
DEF 14A
PCSA Processa Pharmaceuticals Inc
22 Apr 21
Definitive proxy
2:00pm
, incentivize, and retain our executive talent. Further, our executive compensation program is based on market best practices to ensure that it is appropriately … years so that we can continue to incentivize and retain the key contributors to our business, as described in greater detail in this proposal. Amended
10-K
2020 FY
PCSA Processa Pharmaceuticals Inc
24 Mar 21
Annual report
8:00pm
of certain federal healthcare programs, incentivize manufacturers to lower the list price of their products and reduce the out-of-pocket costs of drug
424B4
PCSA Processa Pharmaceuticals Inc
5 Oct 20
Prospectus supplement with pricing info
4:16pm
healthcare programs, incentivize manufacturers to lower the list price of their products and reduce the out-of-pocket costs of drug products paid
S-1/A
PCSA Processa Pharmaceuticals Inc
30 Sep 20
IPO registration (amended)
4:06pm
competition, increase the negotiating power of certain federal healthcare programs, incentivize manufacturers to lower the list price
S-1/A
PCSA Processa Pharmaceuticals Inc
16 Sep 20
IPO registration (amended)
8:00pm
competition, increase the negotiating power of certain federal healthcare programs, incentivize manufacturers to lower the list price
S-1/A
PCSA Processa Pharmaceuticals Inc
17 Jul 20
IPO registration (amended)
5:25pm
manufacturer competition, increase the negotiating power of certain federal healthcare programs, incentivize manufacturers to lower the list price
10-K
2019 FY
PCSA Processa Pharmaceuticals Inc
5 Mar 20
Annual report
7:00pm
competition, increase the negotiating power of certain federal healthcare programs, incentivize manufacturers to lower the list price of their products
S-1
PCSA Processa Pharmaceuticals Inc
13 Dec 19
IPO registration
5:32pm
, increase the negotiating power of certain federal healthcare programs, incentivize manufacturers to lower the list price of their products and reduce the out
S-1
EX-10
PCSA Processa Pharmaceuticals Inc
13 Nov 12
IPO registration
7:00pm
), and this Agreement is executed pursuant to, and is intended to further incentivize Optionee. All capitalized terms in this Agreement shall have
  • 1